Gerard Griffioen
Chief Tech/Sci/R&D Officer at reMYND NV
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Joris Winderickx | M | - |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | 22 years |
Paul van Dun | M | - |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | 22 years |
Rudy Dekeyser | M | 63 |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | 15 years |
David Devigne | M | - |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | - |
Roger Dassen | M | 59 |
Vrije Universiteit Amsterdam
| 28 years |
Goedele Ertveldt | M | - |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Patrick Roesink | M | - |
Vrije Universiteit Amsterdam
| 2 years |
Hielke H. Sybesma | M | 57 |
Vrije Universiteit Amsterdam
| 1 years |
Sanne Vincent de Boer | M | - |
Vrije Universiteit Amsterdam
| 5 years |
Tarun Brahma | M | 51 |
Vrije Universiteit Amsterdam
| 1 years |
Henry Burgers | M | - |
Vrije Universiteit Amsterdam
| 6 years |
Chrisbert van Kooten | M | 55 |
Vrije Universiteit Amsterdam
| 1 years |
Pieter Hallebeek | M | 48 |
Vrije Universiteit Amsterdam
| 4 years |
Bart van den Huijsen | M | - |
Vrije Universiteit Amsterdam
| 1 years |
Maarten Smits | M | - |
Vrije Universiteit Amsterdam
| 4 years |
Paul Montagne | M | - |
Vrije Universiteit Amsterdam
| 4 years |
Eduard Ruijs | M | 52 |
Vrije Universiteit Amsterdam
| 3 years |
Chimwemwe de Gaay Fortman | F | - |
Vrije Universiteit Amsterdam
| 6 years |
Marc van der Lubbe | M | - |
Vrije Universiteit Amsterdam
| 6 years |
Marc van der Lubbe | M | - |
Vrije Universiteit Amsterdam
| 6 years |
Zaina Ahmed-Karim | F | - |
Vrije Universiteit Amsterdam
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 16 | 76.19% |
Belgium | 5 | 23.81% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gerard Griffioen
- Personal Network